A practical approach to determination of laboratory GC-MS limits of detection.
Determination of limit of detection (LOD) values in a forensic laboratory serves a fundamental forensic requirement for assay performance. In addition to demonstrating assay capability, LOD values can also be used to fulfill certification requirements of a high-volume forensic drug laboratory. The LOD was defined as the lowest concentration of drug that the laboratory can detect in a specimen with forensic certainty at a minimum of 85% of the time. Overall batch acceptance criteria included acceptable quantitation of control materials (within 20% of target), acceptable chromatography (symmetry, peak integration, peak shape, peak, and baseline resolution), retention time within +/-1% of the extracted standard, and mass ion ratios within +/-20% of the extracted standard mass ion ratios. Individual specimen acceptance criteria were the same as the batch acceptance criteria excluding the quantitation requirement. Data were collected from all instruments on different runs. A minimum of ten data points was required for each certified instrument, and a minimum of 85% of data points was acceptable. Quantitation within +/-20% of the LOD concentration was not required, but acceptable mass ratios were required. Data points with poor chromatography (internal standard failed mass ratios; interference of the baseline, for example, shoulders; asymmetry; and baseline resolution) was omitted from the acceptable rate calculation. Data points with good chromatography with failed mass ion ratios were included in the acceptable rate calculation. With these criteria, we established the following LODs: 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid, 2 ng/mL; benzoylecgonine, 5 ng/mL; phencyclidine, 2.5 ng/mL; amphetamine, 150 ng/mL; methamphetamine, 100 ng/mL; codeine, 500 ng/mL; and morphine, 1000 ng/mL.
Underwood
P J
PJ
Forensic Toxicology Drug Testing Laboratory, Fort George G. Meade, Maryland 20755-5235, USA.
Kananen
G E
GE
Armitage
E K
EK
D000662:Amphetamines / Q000032:analysis; D003042:Cocaine / Q000031:analogs & derivatives / Q000032:analysis; D013759:Dronabinol / Q000032:analysis; D005554:Forensic Medicine / Q000379:methods*; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods*; D006801:Humans; D009294:Narcotics / Q000032:analysis; D010622:Phencyclidine / Q000032:analysis; D011786:Quality Control; D012680:Sensitivity and Specificity; D015813:Substance Abuse Detection / Q000379:methods
D000662:Amphetamines; D009294:Narcotics; C005618:benzoylecgonine; D013759:Dronabinol; D003042:Cocaine; D010622:Phencyclidine